Phase I Feasibility Trial Opens: Novel Closed-Loop Brain Stimulation System Targets Pre-Seizure Activity in Drug-Resistant Epilepsy

References

1. 1.Epilepsy Australia. (2023). Epilepsy facts and statistics. https://www.epilepsyaustralia.net/about-epilepsy/epilepsy-facts-and-statistics/
2. 2.Frauscher, B., Bartolomei, F., Kobayashi, K., Cimbalnik, J., van 't Klooster, M. A., Rampp, S., Otsubo, H., Höller, Y., Wu, J. Y., Asano, E., Engel Jr, J., Kahane, P., Jacobs, J., & Gotman, J. (2017). High-frequency oscillations: The state of clinical research. Epilepsia, 58(8), 1316-1329. https://doi.org/10.1111/epi.13829
3. 3.Heck, C. N., King‐Stephens, D., Massey, A. D., Nair, D. R., Jobst, B. C., Barkley, G. L., Salanova, V., Cole, A. J., Smith, M. C., Gwinn, R. P., Skidmore, C., Van Ness, P. C., Bergey, G. K., Park, Y. D., Miller, I., Geller, E., Rutecki, P. A., Zimmerman, R., Spencer, D. C., ... NeuroPace RNS System Pivotal Study Investigators. (2014). Two‐year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: final results of the RNS System Pivotal trial. Epilepsia, 55(3), 432-441. https://doi.org/10.1111/epi.12534
4. 4.Höller, Y., Kutil, R., Klaffenböck, L., Thomschewski, A., Höller, P. M., Bathke, A. C., Jacobs, J., Fell, J., Dickten, H., Gerner, A., Leitinger, M., Kalss, G., Kreidenhuber, R., Kuchukhidze, G., Dobesberger, J., & Trinka, E. (2015). High‐frequency oscillations in epilepsy and surgical outcome. A meta‐analysis. Frontiers in Human Neuroscience, 9, 574. https://doi.org/10.3389/fnhum.2015.00574
5. 5.Jacobs, J., Staba, R., Asano, E., Otsubo, H., Wu, J. Y., Zijlmans, M., Mohamed, I., Kahane, P., Dubeau, F., Navarro, V., & Gotman, J. (2012). High-frequency oscillations (HFOs) in clinical epilepsy. Progress in Neurobiology, 98(3), 302-315. https://doi.org/10.1016/j.pneurobio.2012.03.001
6. 6.Kwan, P., Arzimanoglou, A., Berg, A. T., Brodie, M. J., Allen Hauser, W., Mathern, G., Moshé, S. L., Perucca, E., Wiebe, S., & French, J. (2010). Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia, 51(6), 1069-1077. https://doi.org/10.1111/j.1528-1167.2009.02397.x
7. 7.Mayo Clinic. (2024). Acute stimulation for the modulation of epileptic events with a closed-loop brain interchange system in drug resistant epilepsy. ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT06898138
8. 8.Ryvlin, P., Cross, J. H., & Rheims, S. (2014). Epilepsy surgery in children and adults. The Lancet Neurology, 13(11), 1114-1126. https://doi.org/10.1016/S1474-4422(14)70156-5
9. 9.Whitehead, A. L., Julious, S. A., Cooper, C. L., & Campbell, M. J. (2016). Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Statistical Methods in Medical Research, 25(3), 1057-1073. https://doi.org/10.1177/0962280215588241
10. 10.Zijlmans, M., Jiruska, P., Zelmann, R., Leijten, F. S., Jefferys, J. G., & Gotman, J. (2012). High‐frequency oscillations as a new biomarker in epilepsy. Annals of Neurology, 71(2), 169-178. https://doi.org/10.1002/ana.22548